Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity

Early detection of Alzheimer’s disease is required to identify patients suitable for disease-modifying medications and to improve access to non-pharmacological preventative interventions. Prior research shows detectable changes in speech in Alzheimer’s dementia and its clinical precursors. The curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Fristed, Emil, Skirrow, Caroline, Meszaros, Marton, Lenain, Raphael, Meepegama, Udeepa, Papp, Kathryn V, Ropacki, Michael, Weston, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639797/
https://www.ncbi.nlm.nih.gov/pubmed/36381988
http://dx.doi.org/10.1093/braincomms/fcac231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639797/
https://www.ncbi.nlm.nih.gov/pubmed/36381988
http://dx.doi.org/10.1093/braincomms/fcac231

Ejemplares similares